Mundipharma’s analgesic portfolio focuses on the treatment of chronic moderate to severe pain caused by cancer and non-malignant conditions. The Mundipharma arsenal includes immediate and controlled release tablets, and various other formulations such as capsules, injections and patches, suited to the different needs of individual patients. Analgesics include OxyContin^® tablets, OxyNorm^® immediate-release capsules, liquid and concentrate, and solution for injection or infusion, Targin^® tablets, MST CONTINUS^® tablets, TRAMAL^® tablets / capsules, Norspan^® / Sovenor^® transdermal patch and Lignopad^® medicated plaster.*

There is also a fast-growing range of hematological oncology products to be launched in the Asia-Pacific. FODOSINE™ is one of the first to be introduced in the region.*

In addition, Mundipharma markets the very successful BETADINE^® line of antiseptics.

*Approved drug indications and trademarks may differ among countries. For detailed information, please refer to the locally approved full prescribing information